P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

June 2014

Features

FDA Draft Guidances Compound the Compounding Uncertainty

A New List of 503B Outsourcing Facilities Offers No Guarantee of Anything

Compounders who prepare nonpatient-specific prescriptions have been slow to sign up for a new FDA program meant to serve as a de facto “Good Housekeeping” seal of approval. Meanwhile, inspectors are turning up problems wherever they go.
Stephen Barlas

Considerations for the Appropriate Use of Skeletal Muscle Relaxants for the Management Of Acute Low Back Pain

For patients with low back pain, skeletal muscle relaxants are often initiated after failure of first-line analgesics. However, these medications (reviewed in this article) are controversial alternatives that carry risks of adverse effects and increased cost.
Corey Witenko, PharmD, BCPS; Robin Moorman-Li, PharmD, BCACP; Carol Motycka, PharmD, BCACP; Kevin Duane, PharmD; Juan Hincapie-Castillo, PharmD; Paul Leonard, PharmD; and Christopher Valaer, PharmD

Dietary Supplements as Disease-Modifying Treatments in Osteoarthritis: A Critical Appraisal

An array of natural substances purported to possess disease-modifying qualities for osteoarthritis are designated as “dietary supplements” and thus avoid rigorous FDA regulation. Substantial scientific evidence for the efficacy of these agents is elusive.
Philip J. Gregory, PharmD; and Chris Fellner

The Medication Error Prioritization System (MEPS): A Novel Tool in Medication Safety

An integrated health care system used an online database that captured pharmacists’ reports of medication errors and an algorithm that helped classify and prioritize the information to identify patterns and improve safety outcomes.
Alan Polnariev, PharmD, MS, CGP

Meeting Highlights

American Association for Cancer Research and American Psychiatric Association

The American Association for Cancer Research meeting included reports on new agents for breast cancer and melanoma. The American Psychiatric Association meeting offered updates on treatments for bipolar depression, autism, and depression.
Walter Alexander

Departments

Medication Errors

Conservative Prescribing Is Needed To Improve Medication Safety

Matthew Grissinger, RPh, FaScP

Prescription: Washington

FDA Starts New Light-Touch Inspections For Some Imports

Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Apremilast (Otezla) for active psoriatic arthritis, omalizumab (Xolair) for chronic idiopathic urticaria, and grass pollen allergen extract (Oralair) for grass pollen-induced allergic rhinitis with or without conjunctivitis
Marvin M. Goldenberg, PhD, RPh, MS